CHARGE THERAPEUTICS

Serial Number 90739638
606

Registration Progress

Application Filed
May 27, 2021
Under Examination
May 3, 2022
Approved for Publication
Mar 8, 2022
Published for Opposition
Mar 8, 2022
Registered

Trademark Image

CHARGE THERAPEUTICS

Basic Information

Serial Number
90739638
Filing Date
May 27, 2021
Published for Opposition
March 8, 2022
Abandonment Date
October 15, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 15, 2025
Classes
005 042

Rights Holder

STEALTH BIOTHERAPEUTICS INC.

03
Address
Suite 201
123 Highland Ave
Needham, MA 02494

Ownership History

STEALTH BIOTHERAPEUTICS CORP

Original Applicant
03
Monaco MC

STEALTH BIOTHERAPEUTICS INC.

New Owner Before Publication #1
03
NEEDHAM, MA

STEALTH BIOTHERAPEUTICS INC.

Owner at Publication
03
Needham, MA

Legal Representation

Attorney
Tricia L. Schulz

USPTO Deadlines

All Deadlines Cleared

All 3 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

41 events
Date Code Type Description Documents
Oct 15, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 15, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 1, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 1, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
Aug 1, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Aug 1, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Feb 9, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 8, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Feb 8, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Feb 8, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 6, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 4, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Oct 4, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Oct 4, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 27, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 25, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 25, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 25, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 3, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Nov 3, 2022 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Nov 3, 2022 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 15, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 13, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 13, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 13, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 3, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 8, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 8, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 16, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 31, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 28, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jan 28, 2022 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jan 28, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jan 28, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jan 27, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 27, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 27, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 10, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 8, 2021 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Aug 23, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 31, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Biopharmaceutical preparations for the prevention and treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic diseases and disorders; biological preparations for the prevention and treatment of cellular abnormalities
Class 042
Scientific research and development; biopharmaceutical research, development and testing; medical and scientific research in the mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic system fields

Classification

International Classes
005 042

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"